KERA HC

KERA HC is an FDA drug label for the active ingredient HYDROCORTISONE manufactured by Clinical Therapeutic Solutions administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231110.

Generic: HYDROCORTISONE

Manufacturer: Clinical Therapeutic Solutions

Product Type: HUMAN OTC DRUG

Route: TOPICAL

Dosage Form:

NDC: 44577-623

Application: M017

Effective: 20231110

Active Ingredients: Active Ingredient Hydrocortisone-USP 1.00%

Indications & Usage

Uses: Temporarily relieves itching associated with minor skin irritations, inflammations and rashes due to: Excessively Dry Skin, Eczema, Insect Bites, Poison Ivy, Oak or Sumac, Soaps, Detergents, Cosmetics, Jewelery, Seborrheic Dermatitis, Psoriasis Other uses of this product should only be under the advice and supervisor of a doctor

Dosage & Administration

Directions: For itching of skin irritation, inflammation and rashes: Apply to affected area not more than 3 to 4 times daily. Not for use by children under 2 years of age

Contraindications

Not available.

Warnings

Warnings For external use only

Adverse Reactions

Not available.

More from same ingredient

Aloe Cort

Topiderm, Inc.

Anti itch

Weeks & Leo Co., Inc.

Anti-itch Paraben Free

Weeks & Leo Co., Inc.

Anusol HC

Salix Pharmaceuticals, Inc

Assured

Zhejiang Jingwei Pharmaceutic Al Co., Ltd.

Bloop Itch Soothing Topical

Three Nations Corp